Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Cari Clinical Trials

Neither a doctor nor a teaching hospital

Research payments

$241,288

17 payments

Through program year 2025, Cari Clinical Trials is reported as receiving $241,288 in research payments, across 17 payments.

By program year

1 row
Year Kind Amount Payments
2025 Research $241,288 17

Breakdown

Who paid Research payments · program year 2025
  1. Organogenesis Inc. $206,180 10 payments
  2. Regeneron Pharmaceuticals, Inc. $35,108 7 payments
Studies the money was for Research payments · program year 2025
  1. PREPARE PuraPly AM/XT $206,180 10 payments
  2. A Phase 3, Multicenter, Randomized, Open-Label, Sponsor-Blinded, Study to Evaluate REGN7508, A Factor XI Monoclonal Antibody, Versus Apixaban and Enoxaparin for Prophylaxis of Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-APEX) $35,108 7 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record